Stage IVB Prostate Cancer AJCC v8 Clinical Trials in Pontiac, Michigan

5 studies are recruiting for stage ivb prostate cancer ajcc v8 in Pontiac, Michigan right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

1. Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors

   This phase II trial studies how well cabozantinib works in combination with nivolumab and ipilimumab in treating patients with rare genitourinary (GU) tumors that has spread from where it first started (primary site) to other places in the body. Cabozantinib may stop the growth of tumor cells by bl…

   Stage

   Phase 2

   Ages

   18 and older

   Site

   Michigan Healthcare Professionals Pontiac, Pontiac, Michigan

   Locations

   581 in total

   Run by

   National Cancer Institute (NCI)

   See if you can join NCT03866382 on ClinicalTrials.gov

2. Testing the Addition of Docetaxel (Chemotherapy) to the Usual Treatment (Hormonal Therapy and Apalutamide) for Metastatic Prostate Cancer, ASPIRE Trial

   This phase III trial compares the effect of adding docetaxel to hormonal therapy and apalutamide versus hormonal therapy and apalutamide alone in treating patients with prostate cancer that has spread from where it first started (primary site) to other places in the body (metastatic). Docetaxel is …

   Stage

   Phase 3

   Ages

   18 and older

   Site

   Trinity Health Saint Joseph Mercy Oakland Hospital, Pontiac, Michigan

   Locations

   210 in total

   Run by

   Alliance for Clinical Trials in Oncology

   See if you can join NCT06931340 on ClinicalTrials.gov

3. Testing Different Dosing Schedules of the Anti-cancer Drug, Lutetium 177Lu PSMA RLT and Its Effect on Patients With Advanced Prostate Cancer, RECIPROCAL Trial

   This randomized phase III trial examines whether lengthening the dosage interval in an adaptive manner for the prostate cancer drug lutetium 177 Lu PSMA RLT improves quality of life without decreasing lifespan when compared to the standard way this medication is given. This study is for patients wi…

   Stage

   Phase 3

   Ages

   18 and older

   Site

   Trinity Health Saint Joseph Mercy Oakland Hospital, Pontiac, Michigan

   Locations

   129 in total

   Run by

   Alliance for Clinical Trials in Oncology

   See if you can join NCT07200830 on ClinicalTrials.gov

4. Testing Whether the Addition of Carboplatin Chemotherapy to Cabazitaxel Chemotherapy Will Improve Outcomes Compared to Cabazitaxel Alone in People With Castrate-Resistant Prostate Cancer That Has Spread Beyond the Prostate to Other Parts of the Body

   This phase III trial compares the effect of adding carboplatin to the standard of care chemotherapy drug cabazitaxel versus cabazitaxel alone in treating prostate cancer that keeps growing even when the amount of testosterone in the body is reduced to very low levels (castrate-resistant) and that h…

   Stage

   Phase 3

   Ages

   18 and older

   Site

   Hope Cancer Center, Pontiac, Michigan

   Locations

   174 in total

   Run by

   SWOG Cancer Research Network

   See if you can join NCT06470243 on ClinicalTrials.gov

5. Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate Cancer

   This phase III trial studies how well standard systemic therapy with or without definitive treatment (prostate removal surgery or radiation therapy) works in treating participants with prostate cancer that has spread to other places in the body. Addition of prostate removal surgery or radiation the…

   Stage

   Phase 3

   Ages

   18 and older

   Site

   21st Century Oncology-Pontiac, Pontiac, Michigan

   Locations

   338 in total

   Run by

   SWOG Cancer Research Network

   See if you can join NCT03678025 on ClinicalTrials.gov